Michael Waterman
Faculty Member
Last active: 2/12/2015

Levels of adrenodoxin, NADPH-cytochrome P-450 reductase and cytochromes P-45011 beta, P-45021, P-450scc, in adrenal zona fasciculata-reticularis tissue from androgen-treated rats.

Brownie AC, Bhasker CR, Waterman MR
Mol Cell Endocrinol. 1988 55 (1): 15-20

PMID: 3129324 · DOI:10.1016/0303-7207(88)90086-x

Treatment of rats with methylandrostenediol (MAD), an anabolic androgen, caused a profound reduction (65%) in the level of cytochrome P-450 11 beta in rat adrenocortical mitochondria as measured by immunoblots using a specific antibody. The decreases in mitochondrial cytochrome P-450scc (15%) and adrenodoxin (20%) were much less than that observed for cytochrome P-45011 beta. A 35% decrease in adrenal microsomal cytochrome P-450 21 and NADPH-cytochrome P-450 reductase levels was brought about by the treatment with MAD. The data establish that the preferential decrease in adrenal steroid 11 beta-hydroxylase activity associated with androgen treatment results from a decrease in cytochrome P-450 11 beta. This is consistent with the role of 11-deoxycorticosterone in the pathogenesis of androgen-induced hypertension in rats.

MeSH Terms (15)

Adrenal Cortex Adrenodoxin Androstenediols Animals Cytochrome P-450 Enzyme System Female Isoenzymes Kinetics Male Methandriol Mitochondria NADPH-Ferrihemoprotein Reductase Rats Rats, Inbred Strains Reference Values

Connections (1)

This publication is referenced by other Labnodes entities:

Links